Replies to post #61 on GlaxoSmithKline (GSK)

[originalnewt]

News saturday - GSK announces late-stage clinical data for VOTRIENT® (pazopanib) following chemotherapy in women with advanced epithelial ovarian cancer

http://www.gsk.com/media/press-releases/2013/GSK-announces-late-stage-clinical-data-for-Votrient.html